Mary Ann E. Moore - Mar 1, 2022 Form 4 Insider Report for MEDNAX, INC. (MD)

Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Mar 1, 2022
Transactions value $
-$35,792
Form type
4
Date filed
3/3/2022, 04:00 PM
Previous filing
Nov 23, 2021
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +16.3K +114.9% $0.00 30.6K Mar 1, 2022 Direct F2
transaction MD Common Stock Award $0 +16.3K +53.47% $0.00 46.9K Mar 1, 2022 Direct F3
transaction MD Common Stock Tax liability -$35.8K -1.53K -3.25% $23.47 45.4K Mar 1, 2022 Direct F4
holding MD Common Stock 16.9K Mar 1, 2022 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
F2 Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2023, twenty-five percent (25%) of the restricted shares will vest on March 1, 2024 and fifty percent (50%) of the restricted shares will vest on March 1, 2025, subject to the terms of the Plan.
F3 Restricted shares granted pursuant to the Plan in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 8,170 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2022. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2023, twenty-five percent (25%) on March 1, 2024 and fifty percent (50%) on March 1, 2025, subject to the terms of the Plan.
F4 Represents 1,525 restricted shares withheld for payment of taxes upon vesting of shares.